Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Peytavin

Showing results (11-20 of 306) with videos related to

Pageof 31
Sort By:
Journal of Hepatology|July 28, 2016
Reply to: "Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease"Aude Desnoyer, Minh Patrick Lê, Yazdan Yazdanpanah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2010
Pharmacokinetics of the treatment switch from efavirenz to nevirapineJean-Jacques Parienti, Gilles Peytavin, Véronique Reliquet, et al.
Journal of Travel Medicine|September 10, 2003
Severe cardiac toxicity due to halofantrine: importance of underlying heart diseaseOlivier Bouchaud, Fabrice Bruneel, Ricarda Schiemann, et al.
Clinical Pharmacokinetics|November 11, 2003
Once-daily administration of antiretrovirals: pharmacokinetics of emerging therapiesAnne-Marie Taburet, Sabine Paci-Bonaventure, Gilles Peytavin, et al.
Clinical Pharmacology and Therapeutics|November 12, 2002
Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrineBeny Charbit, Laurent Becquemont, Bénédicte Lepère, et al.
The Journal of Antimicrobial Chemotherapy|November 3, 2012
Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapyMinh P Lê, Hind Stitou, Cathia Soulie, et al.
International Journal of STD & AIDS|October 26, 2006
Stability of ritonavir soft capsule formulation in patients with and without a refrigerator at home in Côte d'IvoireChristine Danel, Gilles Peytavin, Raoul Moh, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 18, 2005
Atazanavir: a novel inhibitor of HIV-protease in haemodialysisHassane Izzedine, Vincent Launay-Vacher, Gilles Peytavin, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|October 29, 2017
Bariatric surgery in HIV patients: experience of an Obesity Reference Center in FranceGuillaume Pourcher, Gilles Peytavin, Luminita Schneider, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2021
Placental transfer of doravirine, a recent HIV-1 NNRTI in the ex vivo human cotyledon perfusion modelMinh Patrick Lê, Lucile Pencolé, Gilles Peytavin, et al.
Pageof 31

Showing results (11-20 of 306) with videos related to

Sort By:
Pageof 31
Journal of Hepatology|July 28, 2016
Reply to: "Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease"Aude Desnoyer, Minh Patrick Lê, Yazdan Yazdanpanah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 4, 2010
Pharmacokinetics of the treatment switch from efavirenz to nevirapineJean-Jacques Parienti, Gilles Peytavin, Véronique Reliquet, et al.
Journal of Travel Medicine|September 10, 2003
Severe cardiac toxicity due to halofantrine: importance of underlying heart diseaseOlivier Bouchaud, Fabrice Bruneel, Ricarda Schiemann, et al.
Clinical Pharmacokinetics|November 11, 2003
Once-daily administration of antiretrovirals: pharmacokinetics of emerging therapiesAnne-Marie Taburet, Sabine Paci-Bonaventure, Gilles Peytavin, et al.
Clinical Pharmacology and Therapeutics|November 12, 2002
Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrineBeny Charbit, Laurent Becquemont, Bénédicte Lepère, et al.
The Journal of Antimicrobial Chemotherapy|November 3, 2012
Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapyMinh P Lê, Hind Stitou, Cathia Soulie, et al.
International Journal of STD & AIDS|October 26, 2006
Stability of ritonavir soft capsule formulation in patients with and without a refrigerator at home in Côte d'IvoireChristine Danel, Gilles Peytavin, Raoul Moh, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 18, 2005
Atazanavir: a novel inhibitor of HIV-protease in haemodialysisHassane Izzedine, Vincent Launay-Vacher, Gilles Peytavin, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|October 29, 2017
Bariatric surgery in HIV patients: experience of an Obesity Reference Center in FranceGuillaume Pourcher, Gilles Peytavin, Luminita Schneider, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2021
Placental transfer of doravirine, a recent HIV-1 NNRTI in the ex vivo human cotyledon perfusion modelMinh Patrick Lê, Lucile Pencolé, Gilles Peytavin, et al.
Pageof 31